top of page
15+ Years at Wyss Institute at Harvard University | 10+ Years in Pharmaceutical Development Industry
Modular Vaccine Technology for Known and Unknown Diseases
By Sasha Stafford | Principal Scientist & Founder | Elixis Biosciences & Prodelic Technologies An animation to accompany our "Modular biomaterials vaccine technology protects against multiple pathogens and septic shock" paper, where we describe the development of ciVAX (Composite Infection Vaccine), a modular, injectable biomaterial scaffold designed to provide broad-spectrum protection against lethal bacterial infections and sepsis. Full report @ https://is.gd/CzSnuk #sepsis
Sasha Stafford
Apr 211 min read
Modular Vaccine Platform Against Pathogen X
By Sasha Stafford | Principal Scientist & Founder | Elixis Biosciences & Prodelic Technologies Our "Modular biomaterials vaccine technology protects against multiple pathogens and septic shock" paper describes the development of ciVAX (Composite Infection Vaccine), a modular, injectable biomaterial scaffold designed to provide broad-spectrum protection against lethal bacterial infections and sepsis. Full report @ https://is.gd/CzSnuk #sepsis #vaccines #Biomaterials #medtech #
Sasha Stafford
Apr 102 min read
bottom of page